Transgene SA Profile Avatar - Palmy Investing

Transgene SA

Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clini…

Biotechnology
FR, Illkirch-Graffenstaden [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

Transgene SA has no lobbying expenses in our database.
FY Quarter Lobby Expense [in mil. $] Filing Report Time
No data
End of TNG.PA's Analysis
CIK: - CUSIP: - ISIN: FR0005175080 LEI: - UEI: -
Secondary Listings
TNG.PA has no secondary listings inside our databases.